Treatment with Continuous Positive Airway Pressure Is Not Effective in Patients with Sleep Apnea but No Daytime Sleepiness
Top Cited Papers
- 5 June 2001
- journal article
- clinical trial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 134 (11) , 1015-1023
- https://doi.org/10.7326/0003-4819-134-11-200106050-00007
Abstract
The sleep apnea-hypopnea syndrome is defined by a pathologic number of respiratory events during sleep (the apnea-hypopnea index, defined as the number of apnea and hypopnea episodes per hour) and daytime symptoms (mostly, excessive sleepiness). In patients with the sleep apnea syndrome, treatment with continuous positive airway pressure (CPAP) normalizes both the apnea-hypopnea index and diurnal symptoms. However, the effect of CPAP in persons with a pathologic apnea-hypopnea index without daytime sleepiness is unclear. To investigate the short-term effects of CPAP on quality of life, objective sleepiness, cognitive function, and arterial blood pressure in nonsleepy patients with a pathologic apnea-hypopnea index. Multicenter randomized, placebo-controlled, parallel-group study. Six teaching hospitals in Spain. 55 patients with an apnea-hypopnea index of 30 or greater who did not have daytime sleepiness (Epworth Sleepiness Scale score </= 10). Patients were randomly assigned to receive optimal (n = 29) or sham (n = 25) CPAP and were observed for 6 weeks. Quality of life, objective sleepiness (Multiple Sleep Latency Test score), cognitive function, and arterial blood pressure. The intervention and control groups were similar in terms of mean (+/-SE) age (54 +/- 2 vs. 52 +/- 2 years), apnea-hypopnea index (54 +/- 3 vs. 57 +/- 4), Epworth Sleepiness Scale score (7.0 +/- 0.4 vs. 7.0 +/- 0.4) and adherence to CPAP treatment (5.0 +/- 0.4 vs. 4.0 +/- 0.5 hours/d). Other variables, such as quality of life, cognitive function, and arterial blood pressure, were also similar in both groups before treatment. After 6 weeks of CPAP or sham CPAP, none of these variables changed significantly. In patients with an apnea-hypopnea index of 30 or greater and no subjective daytime sleepiness, CPAP does not modify quality of life, objective sleepiness, vigilance, attention, memory, information processing, visuomotor coordination, or arterial blood pressure. Treatment with CPAP is therefore not indicated in nonsleepy patients with a pathologic apnea-hypopnea index.Keywords
This publication has 22 references indexed in Scilit:
- Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndromeEuropean Respiratory Journal, 2000
- Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical ResearchSleep, 1999
- Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trialThe Lancet, 1999
- Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoeaThe Lancet, 1999
- Night-To-Night Variability in CPAP Use Over the First Three Months of TreatmentSleep, 1997
- Diagnóstico del síndrome de apneas obstructivas durante el sueño. Informe de Consenso del Área de Insuficiencia Respiratoria y Trastornos del SueñoArchivos de Bronconeumología, 1995
- Individual-patient monitoring in clinical practice: are available health status surveys adequate?Quality of Life Research, 1995
- Ambulatory Blood Pressure and Left Ventricular Hypertrophy in Subjects with Untreated Obstructive Sleep Apnoea and Snoring, Compared with Matched Control Subjects, and their Response to TreatmentClinical Science, 1994
- The Occurrence of Sleep-Disordered Breathing among Middle-Aged AdultsNew England Journal of Medicine, 1993
- A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness ScaleSleep, 1991